DH Enchantment Inc.

DH Enchantment Inc., through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong. It primarily serves personal hygiene products distributors. The company was formerly known as Energy Management International, Inc. and changed its name to DH Enchantment Inc. in August 2021. DH Enchantment Inc. was incorporated in 2004 and is based in in Kowloon, Hong Kong.

DH Enchantment Inc. trades as ENMI on OTC. The company is classified in Healthcare / Medical - Distribution and reports in USD.

The current profile places the business in Medical - Distribution. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $686 of revenue and -$156,153 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

DH Enchantment Inc. can be compared against peers such as THC Farmaceuticals, Inc., CuraScientific Corp, Dental Patient Care America, Inc., Comjoyful International Company, Levitee Labs Inc., Paradigm Medical Industries, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $383,131, beta of -2.43, and return on equity of +15.8%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ENMI currently shows total debt of $412,646 and beta of -2.43. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NT 10-K (2025-06-30 00:00:00), 8-K (2025-05-30 00:00:00), 8-K (2025-03-17 00:00:00), DEF 14C (2025-02-24 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.dhgames.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.